- SV Life Sciences participated in 4 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $72,000,000 (averaging $18,000,000 per round).
- PULMOCIDE LIMITED: Venture capital (Series B) ($30M)
- Bardy Diagnostics: Venture capital (Undisclosed amount)
- Pionyr Immunotherapeutics: Venture capital (Series A) ($8M)
- Split Rock Partners
- OrbiMed Advisors
- Oxford Bioscience Partners
Want to see the complete list?